Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
-
Esmark Inc. and Founder James P. Bouchard Charitable Contributions Surpass $120,000 in 2024
-
Erisyon Awarded $2.2M Grant to Develop Diagnostic for Immuno-Oncology Treatment Selection
-
Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Chief Credit Officer of CalPrivate Bank Retires
-
Heritage Distilling Appoints Matt Swann to Board of Directors
-
Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Skyharbour Announces Additional Uranium Property Staking Increasing Total Portfolio to Over 614,000 Hectares in the Athabasca Basin, Saskatchewan
-
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
-
Last Call for Companies to Apply to the World’s Largest Accelerator for Technologies Enabled by Optics, Photonics, and Imaging
-
Armlogi Announces New 500,000 Square Foot Warehouse Sublease in St. Louis Metro Area
-
ThermoFab Announces Expansion with new Mexicali Facility to Support Near-Shoring Initiatives and Global Growth
-
DoubleDown Interactive to Participate at 27th Annual Needham Growth Conference on January 16
-
FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway
-
BlueGrace Logistics Acquires FreightCenter
-
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
-
Provident Bank’s Annual Economic Outlook Survey Shows Business Optimism Amidst Increases in Capital Spending, Hiring and Tech Investment
-
AnewHealth Announces Retirement of CEO John Figueroa and Appointment of President Brian Adams as Successor
-
Magnite and Playwire Partner to Scale High-Impact Ad Formats Through Programmatic Channels
-
St. Louis Blues Partner with Gray Media to Broadcast Three Games Free Over-the-Air on First Alert 4 & Matrix Midwest
-
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on February 10, 2025
-
Sysco to Announce Second Quarter Fiscal Year 2025 Financial Results on January 28
-
Presto Automation Announces Sale of Assets to Consortium Led by Remus Capital
-
Shiplify Reducing Billing Variances for Trinity Logistics
-
DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation
-
Gentex To Unveil the Next Generation of Its Dimmable Glass, Vision, Sensing, and Connectivity Products at CES 2025
-
Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
The RoyaLand Company Ltd. Outlines Vision for the Design & Development of TheRoyal.Land
-
Freshworks to Participate in 27th Annual Needham Growth Conference
-
Top airports and towns in the U.S. struck by lightning in 2024 – Vaisala Xweather Annual Lightning Report is here
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Cargotec’s restated financial information for 2023 and Q1-Q3 2024, MacGregor will be presented as discontinued operations due to the signed sales agreement
-
Raphael Pharmaceutical Announces Positive Proof-of-Concept Clinical Study Results for the Company’s Cannabinoid-Based Formula for the Treatment of Rheumatoid Arthritis
-
Cents Launches Cents Assist, the First AI-Powered Call Center Built for Laundry Businesses
-
PPG to announce fourth-quarter and full-year 2024 results Jan. 30
-
Form 8.3 - Learning Technologies Group Plc
-
Form 8.3 - Renewi Plc
-
Syra Health Wins New Workforce Contract, Announces Existing Contract Extension
-
ParaZero Launches SafeAir Raptor: Advanced Drone Safety System for Anzu Robotics' Raptor Series
-
ParaZero Launches SafeAir Raptor: Advanced Drone Safety System for Anzu Robotics' Raptor Series
-
Form 8.3 - Warpaint London Plc
-
Jeito Capital leads $67.5 million (€64.4 million[1]) Series B financing in XyloCor Therapeutics to develop Novel Gene Therapy in Cardiovascular Disease
-
Jeito Capital leads $67.5 million (€64.4 million[1]) Series B financing in XyloCor Therapeutics to develop Novel Gene Therapy in Cardiovascular Disease
-
BexBack Launches Double Deposit Bonus and 100x Leverage Crypto Trading No KYC
-
Senior Helpers Named a 2025 Top Franchise by Franchise Business Review
-
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
-
Ionstream.ai Builds AI Managed Services Infrastructure on Juniper Networks AI-Native Data Center Solution
-
QurAlis Invited to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Rail Vision Signs Exclusive Agreement with Leading Indian Rail Supplier to Penetrate the Indian Rail Market
-
Osisko Announces Preliminary Q4 2024 Geo Deliveries with Record Annual Cash Margin
